Skip to Content

KU 250 mg (Temozolomide 250 mg)

Pill with imprint KU 250 mg is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Kremers Urban Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for KU 250 mg

Temozolomide 250 mg KU 250 mg

Temozolomide

Imprint
KU 250 mg
Strength
250 mg
Color
White
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Kremers Urban Pharmaceuticals Inc.
National Drug Code (NDC)
62175-0245
Inactive Ingredients
lactose anhydrous, silicon dioxide, sodium starch glycolate type A potato, tartaric acid, stearic acid, gelatin, titanium dioxide, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, ferrosoferric oxide, potassium hydroxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.